Literature DB >> 16650772

Vaccine-derived poliovirus from long term excretors and the end game of polio eradication.

Javier Martín1.   

Abstract

Seven cases of long-term poliovirus excretion in the UK and Ireland are reviewed in this paper. They include a rare case of long-term virus excretion by a healthy child recently found in Ireland and the case with the longest period of vaccine-derived poliovirus excretion by an immunodeficient individual ever known, 18 years. The evolution of viral properties such as antigenic structure, neurovirulence, sensitivity for growth at high temperatures, and differences in nucleotide sequence from the Sabin vaccine strains were studied in detail. The relevance of these cases in the context of the global polio eradication initiative and the design of vaccination strategies for the last stages of eradication and the post-eradication era are discussed.

Entities:  

Mesh:

Year:  2006        PMID: 16650772     DOI: 10.1016/j.biologicals.2006.02.005

Source DB:  PubMed          Journal:  Biologicals        ISSN: 1045-1056            Impact factor:   1.856


  26 in total

1.  Highly divergent type 2 and 3 vaccine-derived polioviruses isolated from sewage in Tallinn, Estonia.

Authors:  Haider Al-Hello; Jaume Jorba; Soile Blomqvist; Riina Raud; Olen Kew; Merja Roivainen
Journal:  J Virol       Date:  2013-09-18       Impact factor: 5.103

2.  Intradermal inactivated poliovirus vaccine: a preclinical dose-finding study.

Authors:  Diana Kouiavskaia; Olga Mirochnitchenko; Eugenia Dragunsky; Efrat Kochba; Yotam Levin; Stephanie Troy; Konstantin Chumakov
Journal:  J Infect Dis       Date:  2014-11-12       Impact factor: 5.226

3.  Feasibility of quantitative environmental surveillance in poliovirus eradication strategies.

Authors:  W J Lodder; A M Buisman; S A Rutjes; J C Heijne; P F Teunis; A M de Roda Husman
Journal:  Appl Environ Microbiol       Date:  2012-03-23       Impact factor: 4.792

4.  Polio, still lurking in the shadows.

Authors:  Anthony N van den Pol
Journal:  J Neurosci       Date:  2013-01-16       Impact factor: 6.167

Review 5.  Emerging Infections and Pertinent Infections Related to Travel for Patients with Primary Immunodeficiencies.

Authors:  Kathleen E Sullivan; Hamid Bassiri; Ahmed A Bousfiha; Beatriz T Costa-Carvalho; Alexandra F Freeman; David Hagin; Yu L Lau; Michail S Lionakis; Ileana Moreira; Jorge A Pinto; M Isabel de Moraes-Pinto; Amit Rawat; Shereen M Reda; Saul Oswaldo Lugo Reyes; Mikko Seppänen; Mimi L K Tang
Journal:  J Clin Immunol       Date:  2017-08-07       Impact factor: 8.317

Review 6.  T Lymphocytes as Measurable Targets of Protection and Vaccination Against Viral Disorders.

Authors:  Anne Monette; Andrew J Mouland
Journal:  Int Rev Cell Mol Biol       Date:  2018-10-24       Impact factor: 6.813

Review 7.  Adjuvants and inactivated polio vaccine: a systematic review.

Authors:  Jennifer Hawken; Stephanie B Troy
Journal:  Vaccine       Date:  2012-10-03       Impact factor: 3.641

8.  Changes in population dynamics during long-term evolution of sabin type 1 poliovirus in an immunodeficient patient.

Authors:  John K Odoom; Zaira Yunus; Glynis Dunn; Philip D Minor; Javier Martín
Journal:  J Virol       Date:  2008-07-02       Impact factor: 5.103

9.  Adaptive immune response to viral infections in the central nervous system.

Authors:  Jane E Libbey; Robert S Fujinami
Journal:  Handb Clin Neurol       Date:  2014

10.  Low Rates of Poliovirus Antibodies in Primary Immunodeficiency Patients on Regular Intravenous Immunoglobulin Treatment.

Authors:  Beatriz T Costa-Carvalho; Kathleen E Sullivan; Patrícia M Fontes; Fernanda Aimé-Nobre; Isabela G S Gonzales; Elaine S Lima; Celso Granato; Maria Isabel de Moraes-Pinto
Journal:  J Clin Immunol       Date:  2018-07-14       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.